PCSK9 and Hypercholesterolemia: A number of studies on 3′UTR-LDLR and PCSK9 regions have suggested that 3′UTR variants could affect these genes' expression by disrupting microRNA-mRNA binding and causing hypercholesterolemia [19, 20].